dc.contributor.author | Corbali, Muhammed Osman | |
dc.contributor.author | EŞKAZAN, Ahmet Emre | |
dc.date.accessioned | 2021-03-02T18:35:20Z | |
dc.date.available | 2021-03-02T18:35:20Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Corbali M. O. , EŞKAZAN A. E. , "Idasanutlin as a new treatment option in improving the therapeutic odyssey of relapsed/refractory AML", FUTURE ONCOLOGY, cilt.16, 2020 | |
dc.identifier.issn | 1479-6694 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b0390154-b0fe-4578-9629-16feb019de50 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/5248 | |
dc.identifier.uri | https://doi.org/10.2217/fon-2020-0218 | |
dc.language.iso | eng | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Idasanutlin as a new treatment option in improving the therapeutic odyssey of relapsed/refractory AML | |
dc.type | Makale | |
dc.relation.journal | FUTURE ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi-Cerrahpaşa , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 14 | |
dc.contributor.firstauthorID | 2280831 | |